Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Study to explore the earliest stages of ovarian cancer
December 3, 2014
Dr.
Barbara Vanderhyden
has recently received $120,000 from the Cancer Research Society to shine some light on the poorly understood origins of ovarian cancer. Most ovarian cancers are thought to arise from the surface layer of cells on the ovaries or fallopian tubes. These surface cells, called OSE cells, can turn into both slow-growing and aggressive cancers. Previous work shows that a protein called PAX2 plays an early role in determining the cancer's aggressiveness. Dr. Vanderhyden will explore how PAX2 is affecting those initial stages of the disease. This is important since patients with more aggressive ovarian cancer respond differently to chemotherapy than those with a less aggressive cancer. Understanding this molecular chain of events could lead to better and earlier diagnosis of ovarian cancer, as well as identify potential therapeutic targets that could stop tumor initiation and progression.
Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with its faculties of Medicine and Health Sciences. The Ottawa Hospital Research Institute includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Research at Ottawa Hospital Research Institute is supported by The Ottawa Hospital Foundation.
For further information, please contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
Office: 613-737-8899 x73687
Cell: 613-323-5680
padmoore@ohri.ca